TFF Pharmaceuticals, Inc.
SEC CIK 1733413 · TFFP · last insider filing 2024-07-08
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Rocamboli Stephen | Director | filed 2019 - 2024 |
| Mills Robert S | Director | filed 2019 - 2024 |
| King Thomas Braxton | Director | filed 2023 - 2024 |
| Roberts Brandi | Director | filed 2022 - 2024 |
| Lee Catherine Chai-zon | Director | filed 2023 - 2024 |
| Weisman Harlan F | Director · President and CEO | filed 2019 - 2024 |
| Patane Michael A | Director | filed 2023 - 2024 |
| Fletcher Aaron G.L. | Director | filed 2019 - 2022 |
| Thurman Randy H | Director | filed 2019 - 2022 |
| Mattes Glenn R. | Director · President and CEO | filed 2019 - 2022 |
| Fairbairn Malcolm | Director | filed 2020 - 2021 |
| Windsor James Brian | Director · Chief Science Officer | filed 2019 - 2020 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Coleman Kirk Allen | Chief Financial Officer | filed 2019 - 2024 |
| Mikhak Zamaneh | Chief Medical Officer | filed 2023 - 2024 |
| Cano Christopher | Chief Operating Officer | filed 2020 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.